Diltiazem hydrochloride tablet labels and packages: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 40: Line 40:
BIOVAIL®
BIOVAIL®
{|
{|
| [[image:cardizem2.jpg|thumb]]
| [[image:cardizem2.jpg|400px|thumb]]
|}
|}


Line 60: Line 60:


{|
{|
| [[image:cardizem3.jpg|thumb]]
| [[image:cardizem3.jpg|400px|thumb]]
|}
|}


Line 80: Line 80:


{|
{|
| [[image:cardizem4.jpg|thumb]]
| [[image:cardizem4.jpg|400px|thumb]]
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CARDIZEM (DILTIAZEM HYDROCHLORIDE) TABLET, COATED [BTA PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=461fe23f-4453-4e3f-9621-0e3fda057d14 | publisher =  | date =  | accessdate = 5 March 2014 }}</ref>
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CARDIZEM (DILTIAZEM HYDROCHLORIDE) TABLET, COATED [BTA PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=461fe23f-4453-4e3f-9621-0e3fda057d14 | publisher =  | date =  | accessdate = 5 March 2014 }}</ref>


Revision as of 06:39, 13 March 2014

Diltiazem
CARDIZEM tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
CARDIZEM LA tablet extended release® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
DILTIAZEM HYDROCHLORIDE injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Diltiazem
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Labels and Packages

PRINCIPAL DISPLAY PANEL - 30 mg Tablets

NDC 6445-771-47

Cardizem® (diltiazem HCl)

30 mg

100 Tablets

Rx ONLY

BIOVAIL®

PRINCIPAL DISPLAY PANEL - 60 mg Tablets

NDC 6445-772-47

Cardizem® (diltiazem HCl)

60 mg

100 Tablets

Rx ONLY

BIOVAIL®

PRINCIPAL DISPLAY PANEL - 90 mg Tablets

NDC 6445-791-47

Cardizem® (diltiazem HCl)

90 mg

100 Tablets

Rx ONLY

BIOVAIL®

PRINCIPAL DISPLAY PANEL - 120 mg Tablets

NDC 6445-792-47

Cardizem® (diltiazem HCl)

120 mg

100 Tablets

Rx ONLY

BIOVAIL®

[1]


References

  1. ↑ "CARDIZEM (DILTIAZEM HYDROCHLORIDE) TABLET, COATED [BTA PHARMACEUTICALS]". Retrieved 5 March 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Diltiazem_hydrochloride_tablet_labels_and_packages&oldid=955328"